BREAKTHROUGH RESEARCH
DR ARUTHA KULASINGHE
Vision is for cancer to be a chronic disease where we are "dying with cancer, and not of it."
Dr. Arutha Kulasinghe's pioneering work has unveiled a remarkable breakthrough - A new spatial mapping technology which enables scientists to see intricate layers of the cellular landscapes in cancer tumors, much like the way we explore the world with Google Maps, from a bird's-eye view down to the granularity of individual streets and neighborhoods.
Harnessing innovative technologies such as liquid biopsy and single-cell analysis and using cutting-edge tools like the Nanostring Technologies for transcriptome analysis and Akoya Biosciences for precise protein characterisation, with integrated machine learning and AI pipeline development, his approach offers a panoramic insight into the tumor microenvironment.
This spatial mapping reveals a wealth of molecular data, including the dynamics of immune infiltrates cellular interactions, metabolic status, and novel biomarkers within the tumor.
Dr. Arutha's groundbreaking research revolutionises our understanding of cancer progression and will allow precise personalised treatments for those impacted by cancer..
Hear more about this cutting-edge research at Cure Cancer's Breaktrough Dinner. Guests can also bid on an one of a kind images taken with this new spatial mapping technology and a exclusive tour of Arutha's lab.
Vision is for cancer to be a chronic disease where we are "dying with cancer, and not of it."
Dr. Arutha Kulasinghe's pioneering work has unveiled a remarkable breakthrough - A new spatial mapping technology which enables scientists to see intricate layers of the cellular landscapes in cancer tumors, much like the way we explore the world with Google Maps, from a bird's-eye view down to the granularity of individual streets and neighborhoods.
Harnessing innovative technologies such as liquid biopsy and single-cell analysis and using cutting-edge tools like the Nanostring Technologies for transcriptome analysis and Akoya Biosciences for precise protein characterisation, with integrated machine learning and AI pipeline development, his approach offers a panoramic insight into the tumor microenvironment.
This spatial mapping reveals a wealth of molecular data, including the dynamics of immune infiltrates cellular interactions, metabolic status, and novel biomarkers within the tumor.
Dr. Arutha's groundbreaking research revolutionises our understanding of cancer progression and will allow precise personalised treatments for those impacted by cancer..
Hear more about this cutting-edge research at Cure Cancer's Breaktrough Dinner. Guests can also bid on an one of a kind images taken with this new spatial mapping technology and a exclusive tour of Arutha's lab.
Dr Arutha Kulasinghe is a Group Leader at the University of Queensland and the Scientific Director of the Queensland Spatial Biology Centre at the Wesley Research Institute.
Dr Kulasinghe has pioneered spatial transcriptomics and proteomics in the Asia-Pacific region, contributing to world-first studies for lung cancer, head and neck cancer, and skin cancer. His research aims to understand the underlying pathobiology by using an integrative multi-omics approach.
In 2023, Arutha was named Cure Cancer’s Researcher of the Year and had his work published in prestigious journals including Immunology, European Respiratory Journal, Immunology & Cell Biology, and GEN Biotechnology.
#breakthroughdinner
@curecancerau
